Sign up to view this video Join Now Commercialization, • 9/19/25 Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next What Matters to Payers: Conversations You Should Start During Phase 2 You Might Also Like Reducing Patient Burden in Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Optimizing CRO and Vendor Selection - Examples from the Field Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization
Sign up to view this video Join Now Commercialization, • 9/19/25 Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next What Matters to Payers: Conversations You Should Start During Phase 2 You Might Also Like Reducing Patient Burden in Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Optimizing CRO and Vendor Selection - Examples from the Field Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization
